AD	Alzheimer’s disease
Aβ	Beta-amyloid
HPA	Hypothalamic–pituitary–adrenal axis
ADLs	Activities of daily living
ADNI	Alzheimer’s Disease Neuroimaging Initiative
BPSD	Behavioral and psychological symptoms of dementia
NPI	Neuropsychiatric Inventory
IASP	International Association for the Study of Pain
APS	Abbey Pain Scale
CMAI	Cohen–Mansfield Agitation Inventory
CIND	Cognitive impairment, no dementia
MOS SF-36	Medical Outcomes Survey SF-36-Item
MOBID-2	Mobilization–Observation–Behavior–Intensity–Dementia-2
ICC	Test–retest reliability
SPTP	Responsiveness to stepwise pain treatment protocol
DCM	Dementia Care Mapping
NOR	Novel Object Recognition Test
SNI	Sciatic nerve injury
EPM	Elevated plus maze
ANH	Adult hippocampal neurogenesis
CXCR2	C-X-C motif chemokine receptor 2
OFT	Open-field test
SPT	Sucrose preference test
FST	Forced swim test
IL-1β	Interleukin-1β
TNF-α	Tumor necrosis factor-alpha
ROS	Reactive oxygen species
ECS	Endocannabinoid system
AEA	Anandamide
2-AG	2-Arachidonoylglycerol
FAAH	Fatty acid amide hydrolase
CRH	Corticotropin-releasing hormone
ACTH	Adrenocorticotropic hormone
ATP	Adenosine triphosphate
iNOS	Inducible nitric oxide synthase
AA	Arachidonic acid
NDMA receptors	N-Methyl-D-Aspartate receptors
NLRP3	NLR Family Pyrin Domain Containing 3
cGAS	Cyclic GMP-AMP synthase
STING	Stimulator of interferon genes
TLR9	Toll-like receptor 9
IFN	Interferon
TMS	Transcranial magnetic stimulation
tDCS	Transcranial direct current stimulation